Micafungin Sodium Injection — FDA Drug Shortage

To Be Discontinued — Par Health, USA LLC

The FDA lists a drug shortage record for Micafungin Sodium Injection (injection) from Par Health, USA LLC with status To Be Discontinued. The shortage was first posted on Sep 11, 2026.

Shortage details

Status
To Be Discontinued
Company
Par Health, USA LLC
Package NDC
42023-230-10
Dosage Form
Injection
Presentation
Micafungin Sodium, Injection, 20 mg/1 mL (NDC 42023-230-10)
Initial Posting
Sep 11, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.